Surgery for Colorectal Cancer: 506 Real Stories

506 stories match colorectal cancer and surgery. 389 of them mention chemotherapy.

Cancer Stories

A patient, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

A R M

Patient Info: A R M | Stage III

They report that the colorectal cancer is in remission after surgery and chemotherapy.

Our Cancer Stories
OutcomeCancer-Free / NED
Li, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Li's Patient Story

Patient Info: Li Zong

Li Zong remained on chemotherapy and targeted therapy while considering future hospice and palliative care.

Our Cancer Stories
OutcomeCare Ongoing
A patient, who was diagnosed with Colorectal CancerColorectal Cancer

Colon cancer at age 27 in a man later diagnosed with Lynch syndrome

Patient Info: Anonymized, Male, Under 40

Biomarkers: Germline pathogenic MSH2 variant NM_000251.2:c.942+3A>T identified later

The first colon cancer remained disease-free after partial colectomy and adjuvant chemotherapy; years later, he died after decline from metastatic pheochromocytoma.

PubMed Central
OutcomeIn Memory
Elizabeth, who was diagnosed with Stage III Colorectal AdenocarcinomaColorectal Cancer

Stage III Colorectal Adenocarcinoma: Elizabeth's Survivor Story

Patient Info: Elizabeth, Female | Stage III

After treatment for a local recurrence, Elizabeth was declared cancer-free in February 2025 and continues to cope with fear of recurrence and life with a permanent ostomy.

Our Cancer Stories
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

A second colon cancer leading to a Lynch syndrome diagnosis

Patient Info: Anonymized, Male, 40s

Biomarkers: Complete loss of MSH2 and MSH6 nuclear staining in the cecal tumor; germline pathogenic MSH2 variant NM_000251.2:c.942+3A>T; Lynch syndrome.

The cecal cancer was treated with complete colectomy, while later presumed recurrences were ultimately identified as meningiomas and metastatic pheochromocytoma; he died after the pheochromocytoma progressed.

PubMed Central
OutcomeIn Memory
Barbara, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Barbara's Survivor Story

Patient Info: Barbara, Female, 40s

As of October 2021, Barbara described life after completed colon-cancer treatment, including survivorship, parenting, and a stronger perspective; recurrence was not described in this edited video.

The Patient Story
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

A Severe Delayed Immune Reaction After Treatment for Metastatic Colon Cancer

Patient Info: Anonymized, Male, 70+ | Stage IV

Metastatic Site: liver

He recovered from repeated episodes of severe cytokine release syndrome after prolonged corticosteroids, completed adjuvant FOLFOX and CV301 without nivolumab, and had no further CRS episodes.

PubMed Central
OutcomeCare Ongoing
Brandon, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Brandon's Survivor Story

Patient Info: Brandon Dale, Male, 50s | Stage III

As of April 2021, Brandon was cancer-free 3 years after Stage III rectal cancer treatment, living normally with a permanent colostomy.

Cleveland Clinic
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Severe immune thrombocytopenia during treatment for metastatic colon cancer

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: KRAS-mutated; microsatellite stable; BRAF-wild type.

Metastatic Site: bilateral ovaries; pelvis; peritoneum; mesenteric…

After multiple metastatic recurrences and treatment changes, she died from progressive colon cancer; oxaliplatin had been permanently stopped after antibody-confirmed immune thrombocytopenia.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Bilateral adrenal bleeding during bevacizumab treatment for metastatic colon cancer

Patient Info: Anonymized, Male, 50s | Stage IV

Biomarkers: RAS-mutant; BRAF-wild type; microsatellite stable.

Metastatic Site: peritoneum; liver; lung

Despite multiple systemic and local treatments, his metastatic colon cancer progressed in the liver and peritoneum, and he died from disease progression in November 2018.

PubMed Central
OutcomeIn Memory
Lee, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Lee's Survivor Story

Patient Info: Lee Jones, Male, 50s | Stage IV

Metastatic Site: Liver

As of February 2021, Lee reported no evidence of colon cancer since 2011 after treatment for Stage IV colon cancer with liver metastases, recurrence, chemotherapy, colon surgery, and liver surgery.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Rectal cancer liver surgery in a woman with mitochondrial disease

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: liver; lungs; para-aortic lymph nodes

Three months after rectal and liver surgery, CT showed multiple lung metastases and para-aortic lymph-node metastasis, and FOLFIRI chemotherapy was resumed.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Rectal cancer that later spread to the vagina

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: vagina

The isolated vaginal metastasis was surgically removed and followed by another 12 cycles of chemotherapy.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage I Colorectal AdenocarcinomaColorectal Cancer

Perforated appendicitis after surgery for stage I rectal cancer

Patient Info: Anonymized, Male, 70+ | Stage I

He recovered well after appendicectomy, was doing well at the four-week review, and remained under intensive rectal-cancer follow-up with community stoma and wound-care support.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Metastatic Right-Sided Colon Cancer With an NRG1 Fusion

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: KRAS mutation; POMK-NRG1 fusion

Metastatic Site: liver|lungs

He had persistent metastatic disease after 16 months of afatinib and entered a phase I trial in January 2020.

PubMed Central
OutcomeCare Ongoing
Kenneth, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Kenneth's Patient Story

Patient Info: Kenneth | Stage III

About 2 years after diagnosis, Kenneth was still undergoing treatment for Stage III colorectal cancer in late 2023.

Our Cancer Stories
OutcomeCare Ongoing
Kyle, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Stage IV Colorectal Adenocarcinoma: Kyle's Survivor Story

Patient Info: Kyle, Under 40 | Stage IV

Kyle was 19 months NED and off treatment after Stage IV colon adenocarcinoma, following about 30 months of chemotherapy and targeted therapy.

Our Cancer Stories
OutcomeCancer-Free / NED
Mel, who was diagnosed with Stage I Colorectal CancerColorectal Cancer

Stage I Colorectal Cancer: Mel's Survivor Story

Patient Info: Mel | Stage I

Cancer-free after partial colectomy and continued recovery after choosing not to receive chemotherapy.

Our Cancer Stories
OutcomeCancer-Free / NED
Cleo, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Cleo's Survivor Story

Patient Info: Cleo | Stage III

Cleo completed active treatment and reports that she is in remission more than 3 years after her February 2021 diagnosis.

Our Cancer Stories
OutcomeCancer-Free / NED
Amanda, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Stage IV Colorectal Adenocarcinoma: Amanda's Patient Story

Patient Info: Amanda, Under 40 | Stage IV

She remains on ongoing treatment for Stage IV disease and describes the cancer as pretty stable while maintaining a good quality of life.

Our Cancer Stories
OutcomeStable Disease
A patient, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Colon Cancer With an MLH1 Deletion and Lynch Syndrome

Patient Info: Anonymized, Male, Under 40 | Stage III

Biomarkers: dMMR with loss of MLH1 and PMS2. Familial MLH1 c.1057_1060delGCTG frameshift deletion identified; its clinical significance had not previously been reported.

The colon cancer progressed rapidly despite postoperative and second-line therapy, and he died from multiple organ failure one week after pembrolizumab was started.

PubMed Central
OutcomeIn Memory